Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Mitsuo OBANA"'
Autor:
Kazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Masahiro Takihata, Tomoya Umezono, Shun Ito, Daisuke Suzuki, Hiroshi Takeda, Akira Kanamori, Hisakazu Degawa, Hareaki Yamamoto, Hideo Machimura, Atsuko Mokubo, Keiichi Chin, Mitsuo Obana, Toshimasa Hishiki, Kouta Aoyama, Shinichi Nakajima, Shinichi Umezawa, Hidetoshi Shimura, Togo Aoyama, Kazuyoshi Sato, Masaaki Miyakawa
Publikováno v:
Clinical and Experimental Hypertension, Vol 41, Iss 7, Pp 637-644 (2019)
Decrease in blood pressure contributes to the reno-protective effects of sodium-glucose cotransporter 2 inhibitors; however, its relationship with home monitoring of blood pressure is unclear. We retrospectively analyzed 101 visiting members of the K
Externí odkaz:
https://doaj.org/article/b1b31d2ac3f746d1be93392f3402d38a
Autor:
Kazuo Kobayashi, Masao Toyoda, Noriko Kaneyama, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Masahiro Takihata, Tomoya Umezono, Shun Ito, Daisuke Suzuki, Hiroshi Takeda, Akira Kanamori, Hisakazu Degawa, Hareaki Yamamoto, Hideo Machimura, Atsuko Mokubo, Keiichi Chin, Mitsuo Obana, Toshimasa Hishiki, Kouta Aoyama, Shinichi Nakajima, Shinichi Umezawa, Hidetoshi Shimura, Togo Aoyama, Masaaki Miyakawa
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Aim. The renoprotective effect of sodium-glucose cotransporter 2 inhibitors is thought to be due, at least in part, to a decrease in blood pressure. The aim of this study was to determine the renal effects of these inhibitors in low blood pressure pa
Externí odkaz:
https://doaj.org/article/1fa7d3057ac64d3b92a640d8898447ba
Autor:
Atsuko Mokubo, Masahiko Takai, Mizuki Kaneshiro, Takehiro Kawata, Akira Kanamori, Yasushi Tanaka, Tetsuo Takuma, Ikuro Matsuba, Akira Kubota, Mitsuo Obana, Shinichi Umezawa, Taisuke Kikuchi, Hideo Machimura, Hiroshi Takeda, Yoko Matsuzawa, Tetsuya Motomiya, Masahiro Takihata, Kotaro Iemitsu, Hajime Maeda, Masaaki Miyakawa, Shogo Ito, Yasuo Terauchi, Taro Asakura
Publikováno v:
Diabetes Technology & Therapeutics. 22:228-234
Background: Sodium/glucose cotransporter-2 (SGLT2) inhibitors improve glycemic control and reduce body weight by increasing glycosuria. Although a compensatory increase of food intake has been repo...
Autor:
Hajime Maeda, Tetsuya Motomiya, Takehiro Kawata, Shinichi Umezawa, Kotaro Iemitsu, Akira Kubota, Masaaki Miyakawa, Mizuki Kaneshiro, Masahiko Takai, Mitsuo Obana, Tetsuo Takuma, Hideo Machimura, Hiroshi Takeda, Shogo Ito, Akira Kanamori, Taisuke Kikuchi, Yoko Matsuzawa, Ikuro Matsuba, Yasuo Terauchi, Atsuko Mokubo, Taro Asakura, Masahiro Takihata
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f478f05116b4316eee572e538c60084f
https://doi.org/10.1111/dom.14508/v2/response1
https://doi.org/10.1111/dom.14508/v2/response1
Autor:
Mitsuo Obana, Masaaki Miyakawa, Tetsuya Motomiya, Yasuo Terauchi, Shogo Ito, Taro Asakura, Atsuko Mokubo, Kotaro Iemitsu, Hideo Machimura, Masahiko Takai, Hajime Maeda, Akira Kanamori, Taisuke Kikuchi, Shinichi Umezawa, Akira Kubota, Yoko Matsuzawa, Tetsuo Takuma, Ikuro Matsuba, Masahiro Takihata, Takehiro Kawata, Mizuki Kaneshiro, Hiroshi Takeda
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 23(12)
Aim Long-term changes in body composition associated with SGLT2 inhibitors have not been characterized. Materials and methods In this multicenter, single-arm, open-label study, 107 subjects with type 2 diabetes were treated, as add-on therapy, with c
Autor:
Ikuro Matsuba, Kotaro Iemitsu, Takehiro Kawata, Takashi Iizuka, Masahiro Takihata, Masahiko Takai, Shigeru Nakajima, Nobuaki Minami, Shinichi Umezawa, Akira Kanamori, Hiroshi Takeda, Shogo Ito, Taisuke Kikuchi, Hikaru Amemiya, Mizuki Kaneshiro, Atsuko Mokubo, Tetsuro Takuma, Hideo Machimura, Keiji Tanaka, Taro Asakura, Akira Kubota, Sachio Aoyagi, Kazuhiko Hoshino, Masashi Ishikawa, Mitsuo Obana, Nobuo Sasai, Hideaki Kaneshige, Masaaki Miyakawa, Yasushi Tanaka, Yasuo Terauchi
Publikováno v:
Journal of Endocrinology and Metabolism. 9:151-158
Autor:
Nobuo Sasai, Tetsuya Motomiya, Kotaro Iemitsu, Hajime Maeda, Atsuko Mokubo, Hikaru Amemiya, Hiroshi Takeda, Akira Kanamori, Tomoyuki Iwasaki, Takehiro Kawata, Hideaki Kaneshige, Takashi Iizuka, Fuyuki Minagawa, Masashi Ishikawa, Goro Uehara, Mizuki Kaneshiro, Yasushi Tanaka, Tatsuya Saito, Keiji Tanaka, Yasuo Terauchi, Ikuro Matsuba, Nobuaki Minami, Hideo Machimura, Shin Honda, Shigeru Nakajima, Mitsuo Obana, Masaaki Miyakawa, Yukiko Miyairi, Kazuhiko Hoshino, Masahiko Takai, Manabu Waseda, Akira Kubota, Kiyokazu Matoba, Tetsuo Takuma, Shinichi Umezawa
Publikováno v:
Journal of Clinical Medicine Research
Background: Sitagliptin, the first dipeptidyl peptidase-4 inhibitor, has demonstrated efficacy and safety as monotherapy and as add-on therapy to oral antidiabetic agents or insulin. However, there have been few reports about sitagliptin in elderly p
Autor:
Kotaro Iemitsu, Takehiro Kawata, Takashi Iizuka, Masahiro Takihata, Masahiko Takai, Shigeru Nakajima, Nobuaki Minami, Shinichi Umezawa, Akira Kanamori, Hiroshi Takeda, Shogo Ito, Taisuke Kikuchi, Hikaru Amemiya, Mizuki Kaneshiro, Atsuko Mokubo, Tetsuo Takuma, Hideo Machimura, Keiji Tanaka, Taro Asakura, Akira Kubota, Sachio Aoyagi, Kazuhiko Hoshino, Masashi Ishikawa, Yoko Matsuzawa, Mitsuo Obana, Nobuo Sasai, Hideaki Kaneshige, Fuyuki Minagawa, Tatsuya Saito, Kazuaki Shinoda, Masaaki Miyakawa, Yasushi Tanaka, Yasuo Terauchi, Ikuro Matsuba
Publikováno v:
Journal of Endocrinology and Metabolism. 9:51-62
Autor:
Keiichi Chin, Masahiro Takihata, Kazuyoshi Sato, Hisakazu Degawa, Shun Ito, Togo Aoyama, Masaaki Miyakawa, Shinichi Nakajima, Atsuko Mokubo, Akira Kanamori, Daisuke Suzuki, Hidetoshi Shimura, Hiroshi Takeda, Nobuo Hatori, Moritsugu Kimura, Hiroyuki Sakai, Hareaki Yamamoto, Shinichi Umezawa, Toshimasa Hishiki, Mitsuo Obana, Takayuki Furuki, Tomoya Umezono, Kazuo Kobayashi, Hideo Machimura, Masao Toyoda, Kouta Aoyama
Publikováno v:
Clinical and Experimental Hypertension. 41:637-644
Decrease in blood pressure contributes to the reno-protective effects of sodium-glucose cotransporter 2 inhibitors; however, its relationship with home monitoring of blood pressure is unclear. We retrospectively analyzed 101 visiting members of the K
Autor:
Toshimasa Hishiki, Akira Kanamori, Atsuko Mokubo, Kouta Aoyama, Hidetoshi Shimura, Nobuo Hatori, Shinichi Nakajima, Daisuke Suzuki, Takayuki Furuki, Tomoya Umezono, Moritsugu Kimura, Masao Toyoda, Kazuo Kobayashi, Keiichi Chin, Masahiro Takihata, Hisakazu Degawa, Hiroshi Takeda, Mitsuo Obana, Shun Ito, Kazuyoshi Sato, Masaaki Miyakawa, Togo Aoyama, Hareaki Yamamoto, Hiroyuki Sakai, Shinichi Umezawa, Hideo Machimura
Publikováno v:
Diabetes and Vascular Disease Research. 16:103-107
The aim of this study was to assess the renal effects of the glucose-lowering SGLT2 inhibitors in Japanese type 2 diabetes mellitus patients with chronic kidney disease.The Kanagawa Physicians Association maintains a registry of patients who visit th